Cargando…

Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions

Studies that generate real-world evidence on the effects of medical products through analysis of digital data collected in clinical practice provide key insights for regulators, payers, and other healthcare decision-makers. Ensuring reproducibility of such findings is fundamental to effective eviden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shirley V., Sreedhara, Sushama Kattinakere, Schneeweiss, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430007/ https://www.ncbi.nlm.nih.gov/pubmed/36045130 http://dx.doi.org/10.1038/s41467-022-32310-3

Ejemplares similares

Real-World Evidence Prediction of a Phase IV Oncology Trial: Comparative Degarelix vs Leuprolide Safety
por: Merola, David, et al.
Publicado: (2022)

Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation
por: Simon, Tracey G., et al.
Publicado: (2023)

2944. Comparative Effectiveness and Safety of 5-7 days versus 10 days of Antibiotics for Acute Bacterial Sinusitis in Children
por: Savage, Timothy J, et al.
Publicado: (2023)

Association between initiation of fluoroquinolones and hospital admission or emergency department visit for suicidality: population based cohort study
por: Wang, Junyi, et al.
Publicado: (2022)

Comparability of family planning quality of care measurement tools in low-and-middle income country settings: a systematic review
por: Hazel, Elizabeth, et al.
Publicado: (2021)

Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR‐ISPE Special Task Force on real‐world evidence in health care decision making
por: Berger, Marc L., et al.
Publicado: (2017)

Real World-Evidence for Regulatory Use Decision Aid: An Interactive Tool To Inform Clinical Development and Regulatory Strategies
por: Burns, Leah, et al.
Publicado: (2022)

Use of real world data to improve drug coverage decisions in China
por: Wang, Wen, et al.
Publicado: (2023)

Real-world evidence for regulatory decision-making: updated guidance from around the world
por: Burns, Leah, et al.
Publicado: (2023)

Conducting Real-world Evidence Studies on the Clinical Outcomes of Diabetes Treatments
por: Schneeweiss, Sebastian, et al.
Publicado: (2021)

Informing real-world practice with real-world evidence: the value of PRECIS-2
por: Neta, Gila, et al.
Publicado: (2018)

Contribution of Real‐World Evidence in European Medicines Agency's Regulatory Decision Making
por: Bakker, Elisabeth, et al.
Publicado: (2022)

HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real‐world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force
por: Wang, Shirley V., et al.
Publicado: (2022)

Real‐world evidence to support regulatory decision‐making for medicines: Considerations for external control arms
por: Burcu, Mehmet, et al.
Publicado: (2020)

Use of Real-World Evidence for Drug Regulatory Decisions in China: Current Status and Future Directions
por: Li, Pei, et al.
Publicado: (2023)

Real-world evidence enhances decision making
por: Malone, Daniel C
Publicado: (2020)

Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
por: Cave, Alison, et al.
Publicado: (2019)

STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies
por: Wang, Shirley V, et al.
Publicado: (2021)

EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-making
por: Plueschke, Kelly, et al.
Publicado: (2018)

Modernizing Regulatory Evidence with Trials and Real-World Studies
por: Dreyer, Nancy A., et al.
Publicado: (2020)

Examining the Use of Real‐World Evidence in the Regulatory Process
por: Beaulieu‐Jones, Brett K., et al.
Publicado: (2019)

Pharmacoepidemiology Research-Real-World Evidence for Decision Making
por: Bérard, Anick
Publicado: (2021)

Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions
por: Roberts, Melissa H., et al.
Publicado: (2020)

Transferability of real-world data across borders for regulatory and health technology assessment decision-making
por: Jaksa, Ashley, et al.
Publicado: (2022)

Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data
por: Jang, Ha Young, et al.
Publicado: (2022)

Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable
por: Dreyer, Nancy A.
Publicado: (2018)

The Current Landscape and Emerging Applications for Real‐World Data in Diagnostics and Clinical Decision Support and its Impact on Regulatory Decision Making
por: Baumfeld Andre, Elodie, et al.
Publicado: (2022)

A Structured Preapproval and Postapproval Comparative Study Design Framework to Generate Valid and Transparent Real‐World Evidence for Regulatory Decisions
por: Gatto, Nicolle M., et al.
Publicado: (2019)

Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis
por: Cohen, Stanley B., et al.
Publicado: (2020)

A real world example of coverage with evidence development in Australia - ipilimumab for the treatment of metastatic melanoma
por: Kim, Hansoo, et al.
Publicado: (2018)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

USING REAL-WORLD EVIDENCE TO SUPPORT THE FDA REGULATORY APPROVAL: METHODOLOGICAL CONSIDERATIONS
por: Lu, Kevin, et al.
Publicado: (2022)

Payer perceptions of the use of real-world evidence in oncology-based decision making
por: Brixner, Diana, et al.
Publicado: (2021)

Correlation between vaccine coverage and the COVID‐19 pandemic throughout the world: Based on real‐world data
por: Huang, Chao, et al.
Publicado: (2022)

Regulatory Approval With Real-World Data From Regulatory Science Perspective in Japan
por: Maeda, Hideki, et al.
Publicado: (2022)

Proceed with Caution When Using Real World Data and Real World Evidence
por: Kim, Hun-Sung, et al.
Publicado: (2019)

4505 Implementation of Real-World Data and Real-World Evidence in Clinical Studies
por: Pham, Jessica, et al.
Publicado: (2020)

Classification Videos Reveal the Visual Information Driving Complex Real-World Speeded Decisions
por: Jalali, Sepehr, et al.
Publicado: (2018)

The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR
por: Khunti, Kamlesh, et al.
Publicado: (2023)

Small But Mighty: The Use of Real‐World Evidence to Inform Precision Medicine
por: Miksad, Rebecca A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nvrch4vjpd3nomg9epjp0l8b06